Delivery Order SPE2DB20D1004-SPE2DB25FNCSB

Award Date 11/14/24
Potential Completion Date 11/15/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award SPE2DB20D3111|SPE2DB25FA6WE was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,127.42 firm fixed-price delivery order is for the supply of 4567423511 ONDANSETRON ODT 4 MG TABLET 30S, with a completion date of March 3, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,806.49 firm fixed-price delivery order is for the supply of 4567632441 ! ONDANSETRON ODT 4 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 20, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,276.75, is for the supply of 4563282959 ! ONDANSETRON ODT 4 MG TABLET 30S, a generic pharmaceutical product. This contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, with ID SPE2DB20D2002|SPE2DB25FL24Z, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,233.38 firm fixed-price delivery order is for the supply of 4567455524 ! ONDANSETRON ODT 4 MG TABLET 30S. The contract has an ultimate completion date of March 5, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $1,095.19, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order, is for the supply of 4567012565 ! ONDANSETRON ODT 4 MG TABLET 30S to the Defense Logistics Agency (DLA). The contract has a firm fixed price pricing type and an ultimate completion date of January 23, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,417.32, is a delivery order for the supply of 4567875628 ! ONDANSETRON ODT 4 MG TABLET 30S. The contract is a firm fixed-price arrangement without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, with ID SPE2DB20D3101|SPE2DB25FRCF7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order valued at $5,176.79, is for the supply of 4567310507 ! ONDANSETRON ODT 4 MG TABLET 30S. The contract has a Firm Fixed Price pricing type and an ultimate completion date of February 20, 2025. This award is part of a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,302.48, is a Firm Fixed Price Delivery Order for the supply of 4566502356 ONDANSETRON ODT 4 MG TABLET 30S. The contract has an ultimate completion date of November 21, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,130.22, is a delivery order for the supply of 4564828382 - ONDANSETRON ODT 4 MG TABLET 30S. The contract has an ultimate completion date of June 7, 2024 and is a firm fixed-price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,631.28 firm-fixed-price delivery order is for the supply of 4564570402 - ONDANSETRON ODT 4 MG TABLET 30S, with a completion date of May 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNCSB
    Delivery Order

This federal contract award SPE2DB20D1004|SPE2DB25FNCSB was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,366.67, is a Delivery Order for the supply of 4566433957 - ONDANSETRON ODT 4 MG TABLET 30S. This contract is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.

Generated 5/20/25, 2:16 PM